How to Advertise Aesthetic Treatments on Social Media Without Breaking the Rules (UK)

Here is the short version. In the UK you cannot advertise Botox or any prescription-only medicine to the public, and that includes your clinic’s organic social posts, your practitioners’ personal accounts, your hashtags and your before-and-after photos. What you can promote is the patient’s concern, the outcome they want, and the consultation. Get that one distinction right and you can market hard and stay compliant.

This guide explains exactly where the line sits, what the regulators are actually enforcing in 2026, and how to build a social presence that brings in consultations without triggering a public ruling against your clinic.

Why this matters more in 2026 than ever before

The rules are not new. The enforcement is. The MHRA issued 47 enforcement notices to aesthetic businesses in 2024 for advertising prescription-only medicines, the majority on Instagram and TikTok. Since 2025 the ASA has been using custom AI to scan social media for non-compliant posts, and the MHRA has gone further still, telling some clinics to remove references to Botox from their websites entirely.

The commercial risk is not just a slap on the wrist. An ASA ruling is published with your clinic’s name on it, and it can rank on Google for people searching for you. In a market built on trust, that is the worst possible first impression. The clinics winning right now are the ones that treat compliance as part of their marketing, not a threat to it.

What the law actually says

Two separate regimes apply to the same content, which is why people get caught off guard.

The law: the Human Medicines Regulations 2012 prohibit advertising prescription-only medicines (POMs) to the public, whether the promotion is direct or indirect.

The advertising code: rule 12.12 of the CAP Code, enforced by the ASA, says the same thing. The ASA treats almost any reference to a POM as promotion.

Breach this and you are breaking the law and breaching the advertising code at the same time. The products that count as POMs include all botulinum toxin brands (Botox, Vistabel, Azzalure, Bocouture, Dysport, Daxxify, Relfydess), dermal fillers that contain a POM such as lidocaine, and hyaluronidase. None of those brand names belong in public-facing marketing.

What counts as advertising on social media

This is where most clinics slip up. The common belief is that only paid ads are regulated. That is wrong. The ASA treats your own organic posts, stories, reels and hashtags as advertising. It applies to your clinic accounts and to your practitioners’ personal accounts.

So a nurse posting “loved doing this lip work today” with a toxin hashtag is, in the eyes of the regulator, running an unlawful advert for a prescription medicine. The platform, the format and whether you paid for reach make no difference.

What you cannot post

• The word “Botox”, or any toxin brand or medical name, directly or indirectly.

• Indirect references the ASA now treats as promotion, including “anti-wrinkle injections”, “anti-wrinkle treatments”, “wrinkle-relaxing injections” and “beautox”. These workarounds used to be tolerated and no longer are.

• Before-and-after photos of toxin treatments.

• Price promotions, discounts or special offers on toxin, for example “toxin, 3 areas, £150” posted to your feed.

• Toxin offered as a competition prize or bundled into a package.

• Endorsements or testimonials that promote the medicine or its results.

• Any claim that implies a specific outcome from the medicine.

What you absolutely can do: the consultation-first model

Here is the part most “what not to do” guides skip. You can still market aggressively. The compliant move is to promote the concern, the outcome and the consultation, not the medicine.

• Speak to the problem the patient has, lines, volume loss, feeling self-conscious, without naming any drug.

• Promote a “consultation for the treatment of lines and wrinkles”. This framing is explicitly acceptable to the ASA.

• Publish genuinely educational, balanced content about your process, safety, aftercare and what a consultation involves.

• Show your team, qualifications, clinic environment and regulatory registrations such as CQC. Credibility is the strongest selling point in a low-trust market.

• Market non-POM treatments freely, within the usual claims rules, and let those carry much of your feed.

• Use real testimonials about the experience and the care, not about the medicine or the results it produced.

The reframe worth internalising: compliant content is usually better content. A consultation-first feed qualifies leads before they book, sets honest expectations and starts the clinical relationship on the right footing. That converts better than a discount on a drug you are not allowed to name.

The narrow website exception (and why social is stricter)

Your website gets a small carve-out that social media does not. You may provide balanced, factual information about a POM as a possible treatment option following a consultation, and you may include it on a price list showing the name and price only, with no product claims, kept off the homepage and not easily found by a casual browser. The consultation, not the product, has to be the focus.

Two hard limits to remember: you cannot share that price list on social media, and the MHRA has been pushing even this exception further, asking some clinics to strip Botox references from their sites altogether. Treat the website allowance as narrow and shrinking, not as a loophole.

Under-18s and ad targeting

Since 1 October 2021 it has been a criminal offence in England to administer botulinum toxin or filler by injection for a cosmetic purpose to anyone under 18, and arranging such treatment is also an offence. Your content must not target or appeal primarily to under-18s, and you should actively exclude under-18s from paid targeting.

Important nuance: the ASA holds you responsible for the reasonably foreseeable reach of your content, not just the audience you intended. If a post designed for adults gets shared into a much younger audience, that is still your problem.

It is not only the ASA: the other rules you are signing up to

• Consumer protection (CMA): pricing must be transparent. A “special offer” that never ends is just your normal price, and presenting it as a discount is misleading. Honour the 14-day cooling-off right on bookings taken online.

• Influencer disclosure: “#gifted” or a casual “thank you” is not enough. Paid or gifted content must be clearly labelled as advertising.

• Professional regulators: if you are registered with the GMC, NMC, GPhC or GDC, their advertising and conduct standards apply on top, and a breach can trigger fitness-to-practise proceedings independently of any ASA action.

What is coming: the new licensing scheme

A bigger shift is on the way, and clinics that prepare for it early will have a marketing advantage. In August 2025 the government confirmed it will introduce a licensing scheme for non-surgical cosmetic procedures in England, built around a red, amber and green risk system. Botox and dermal fillers are expected to sit in the amber tier, with local-authority licensing required for both practitioners and premises, and minimum standards for training, hygiene, insurance and safety.

This is not law yet. A further public consultation was due in early 2026, with the highest-risk procedures restricted first. But the direction is clear, and there is a marketing angle in it: when the scheme lands, being able to show that you are licensed, insured and compliant becomes a competitive advantage, not just a legal box to tick. Start building that credibility into your content now.

A compliant content plan that still books treatments

Putting it together, a social presence that is both compliant and commercial looks like this.

• Lead the feed with non-POM content, education and clinic culture so you are never reliant on the treatments you cannot name.

• Build authority: practitioner credentials, safety standards, behind-the-scenes, and the patient experience.

• Use concern-led hooks, for example “self-conscious about fine lines?”, that route to a consultation rather than to a drug.

• Feature real reviews about trust, care and results that are not tied to a named medicine.

• Run a consistent consultation call to action across every post.

• Keep your paperwork: written marketing consent for any client imagery, and standardised conditions for any photography you are allowed to use.

This is exactly the kind of system a specialist healthcare social media partner builds and runs, so the clinic gets the bookings without carrying the compliance risk.

Quick compliance checklist to action today

• Remove POM brand names and indirect references from all public content, including practitioners’ personal accounts.

• Delete toxin before-and-afters and toxin price promotions from social.

• Rewrite captions around the concern and the consultation.

• Exclude under-18s from targeting and keep content age-appropriate.

• Clearly label all gifted and influencer content as advertising.

• Collect written marketing consent for every client image and testimonial.

• Audit your website price list and POM mentions against the exception rules.

Frequently asked questions

Can I mention Botox on Instagram if I am a registered nurse or doctor?

No. The ban on advertising prescription-only medicines applies regardless of your qualification, and it covers your personal accounts as well as the clinic’s. Being medically qualified does not give you an advertising exemption.

Can I post before-and-after photos of anti-wrinkle injections?

No. Before-and-after images of toxin treatments are treated as promoting a prescription-only medicine and breach the rules, even on your own organic feed.

What can I actually say to advertise injectables?

Market the concern and the consultation. “Book a consultation about lines and wrinkles” is acceptable. Naming or promoting the medicine, or implying its results, is not.

Are dermal fillers treated the same as Botox?

Not always. Many fillers are not prescription-only medicines, so they can be advertised more freely within the normal claims rules. Fillers that contain a POM such as lidocaine, and hyaluronidase, are restricted, and separate safety and licensing changes are on the way.

Is advertising Botox really illegal, or just against ASA rules?

Both. Advertising a prescription-only medicine to the public breaches the CAP Code and breaks the Human Medicines Regulations 2012 at the same time.

Will the new licensing scheme change the advertising rules?

The licensing scheme is about who can perform procedures and where, not about advertising. The ban on promoting prescription-only medicines already applies and is not expected to loosen.

Build a social presence that books, not one that gets banned

Otta is a social media agency built specifically for healthcare and aesthetics brands, which means compliance is not an afterthought. It is built into how we plan content, run paid media and grow your audience. If you want a feed that brings in consultations without risking a public ruling, get in touch and we will show you what a compliant, high-performing aesthetics account looks like.

This article is general guidance, not legal advice. Advertising and cosmetic-procedure rules change, so always check the current ASA CAP Code, MHRA guidance and GOV.UK before publishing.

Sources and further reading

ASA / CAP, advertising botulinum toxin (Botox) products

GOV.UK, crackdown on unsafe cosmetic procedures (August 2025)

House of Commons Library, regulation of non-surgical cosmetic procedures